Connect
← Return to (MAC/MAI) Mycobacterium Avium Complex Pulmonary Disease: Join us
Discussion
(MAC/MAI) Mycobacterium Avium Complex Pulmonary Disease: Join us
MAC & Bronchiectasis | Last Active: Oct 29 5:15pm | Replies (9350)Comment receiving replies
If we have this information maybe we can compile it in a letter to the companies doing the Nitric Oxide studies. Novoclem Therapeutics uses a nitric oxide technology for the treatment of Cystic Fibrosis and other respiratory diseases. http://www.novoclem.com awhitaker@novoclem.com
Contacts
Contact: Chris C Miller, Ph.D. 778-899-0607 miller42@mail.ubc.ca
Locations
Canada, British Columbia
Diamond Centre Recruiting
Vancouver, British Columbia, Canada, V5Z-1L8
Contact: Chris C Miller, Ph.D 778-899-0607 miller42@mail.ubc.ca
Sponsors and Collaborators
University of British Columbia
Novoteris, LLC
Investigators
Principal Investigator: Jeremy D Road, MD Professor
CONTACT
Steven Lisi, Chief Executive Officer
AIT Therapeutics, Inc.
Steve@AIT-Pharm.com
Bob Yedid
LifeSci Advisors, LLC
Bob@LifeSciAdvisors.com
(646) 597 6989
Johannes Lehmann of Technical University of Munich demonstrated that the new inhibitor blocks especially the enzymes Pks13 and Ag85, which play a key role in the development of mycomembranes. beta lactone EZ120
Replies to "If we have this information maybe we can compile it in a letter to the companies..."
@boomexpert my doctor (infectiologist) said the same thing to me. Many people has it but are not diagnosed. He didn’t seem too worry about it but monitored it for 3 or 4 years. With the bronchiectasis it is more dangerous to multiply
@nick52, en anglais on dit Infectious Disease Specialist ou ID physician. En effet, je préfère la phrase "infectiologist". 🙂
Lol thanks Colleen
Connect
@boomerexpert
Awesome. Tdrell